Clinical Trial Details
— Status: Recruiting
Administrative data
| NCT number |
NCT05385354 |
| Other study ID # |
MDP-1 |
| Secondary ID |
|
| Status |
Recruiting |
| Phase |
|
| First received |
|
| Last updated |
|
| Start date |
May 3, 2022 |
| Est. completion date |
May 3, 2024 |
Study information
| Verified date |
December 2023 |
| Source |
Technical University of Munich |
| Contact |
Veit T Phillip, MD |
| Phone |
+498941409350 |
| Email |
veit.phillip[@]tum.de |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Observational
|
Clinical Trial Summary
The maximal diameter of the pancreatic duct will be measured by endoscopic ultrasound at four
different parts:
- Pancreatic head
- Pancreatic neck
- Pancreatic body
- Pancreatic tail
Description:
All patients without pancreatic or biliary disorders undergoing upper-GI endoscopic
ultrasound (EUS) are eligible for the study.
The maximal diameter of the pancreatic duct will be measured by endoscopic ultrasound in
millimeters at four different parts:
- Pancreatic head
- Pancreatic neck
- Pancreatic body
- Pancreatic tail